Skip to main content
SpringerLink
Log in

Outpatient Management of COVID-19

  • Chapter
  • First Online:
Principles in Nursing Practice in the Era of COVID-19

  • 286 Accesses

Abstract

Chapter 8 discusses the management of patients diagnosed with COVID-19 in an outpatient setting. Symptom, medication, and treatment management options are reviewed in an effort to assist nurses caring for patients diagnosed with COVID-19. Guidance on follow-up care is also discussed to provide education for individuals who test positive for the SARS-CoV-2 virus, with or without symptoms.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Fuchs V (2020) Healthcare policy after the COVID-19 pandemic. JAMA 324(3):233–234. https://doi.org/10.1001/jama.2020.10777

    Article  CAS  PubMed  Google Scholar 

  2. Jeffery MM et al (2020) Trends in emergency department visits and hospital admissions in health care systems in 5 states in the first months of the CoViD-19 pandemic in the US. JAMA Intern Med 180(10):1328–1333. https://doi.org/10.1001/jamainternmed.2020.3288

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Wong LE et al (2020) Where are all the patients? Addressing Covid-19 fear to encourage sick patients to seek emergency care. NEJM Catal Innov Care Deliv. https://doi.org/10.1056/CAT.20.0193

  4. Uscher-Pines L et al (2013) Emergency department visits for nonurgent conditions: systematic literature review. Am J Manag Care 19(1):47–59

    PubMed  PubMed Central  Google Scholar 

  5. Durand AC et al (2011) ED patients: How nonurgent are they? Systematic review of the emergency medicine literature. Am J Emerg Med 29(3):333–345. https://doi.org/10.1016/j.ajem.2010.01.003

    Article  PubMed  Google Scholar 

  6. Giannouchos TV et al (2020) Predictors of multiple emergency department utilization among frequent emergency department users in 3 states. Med Care 58(2):137–145. https://doi.org/10.1097/MLR.0000000000001228

    Article  PubMed  Google Scholar 

  7. Maragakis LL. COVID-19 vs. flu. (2021, September 28). https://www.hopkinsmedicine.org/health/conditions-and-diseases/coronavirus/coronavirus-disease-2019-vs-the-flu

  8. World Health Organization. WHO Coronavirus (COVID-19) dashboard. https://covid19.who.int/

  9. Centers for Disease Control and prevention. Mental heal: Coping with stress (2020, July 21). https://www.cdc.gov/mentalhealth/stress-coping/cope-with-stress/index.html

  10. Guan WJ et al (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382:1708–1720. https://doi.org/10.1056/NEJMoa2002032externalicon

    Article  CAS  PubMed  Google Scholar 

  11. Li Q et al (2020) Early transmission dynamics in Wuhan, China, of novel coronavirus-Infected pneumonia. N Engl J Med 382:1199–1207. https://doi.org/10.1056/nejmoa2001316externalicon

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Lauer SA et al (2020) The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: Estimation and application. Ann Intern Med 172(9):577–582. https://doi.org/10.7326/M20-0504externalicon

    Article  PubMed  Google Scholar 

  13. Mehring WM et al (2020) Initial experience with a COVID-19 web-based patient self-assessment Tool. J Gen Intern Med 35:2821

    Article  Google Scholar 

  14. Crane SJ et al (2020) Telemedicine consultations and follow-up of patients with COVID-19. Mayo Clin Proc 95:S33

    Article  CAS  Google Scholar 

  15. Cohen PA et al (2020) The early natural history of SARS-CoV-2 infection: clinical observations from an urban, ambulatory COVID-19 clinic. Mayo Clin Proc 95:1124

    Article  CAS  Google Scholar 

  16. Wang W et al (2020) Detection of SARS-CoV-2 in different types of clinical specimens. JAMA 323:1843

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Liu Y et al (2020) Viral dynamics in mild and severe cases of COVID-19. Lancet Infect Dis 20:656

    Article  CAS  Google Scholar 

  18. Stokes EK et al (2020) Coronavirus disease 2019 case surveillance—United States, January 22–May 30, 2020. MMWR Morb Mortal Wkly Rep 69:759–765. https://www.cdc.gov/mmwr/volumes/69/wr/pdfs/mm6924e2-H.pdf

    Article  CAS  Google Scholar 

  19. NIH. COVID-19 treatment guidelines: Supplements (2011, February 11). https://www.covid19treatmentguidelines.nih.gov/therapies/supplements/summary-recommendations/

  20. NIH. Therapeutic management of non-hospitalized adults with COVID-19) (2021, July 8). https://www.covid19treatmentguidelines.nih.gov/management/clinical-management/nonhospitalized-adults%2D%2Dtherapeutic-management/

  21. Jiang S et al (2020) Neutralizing antibodies against SARS-CoV-2 and other human coronaviruses. Trends Immunol 41(5):355–359. https://www.ncbi.nlm.nih.gov/pubmed/32249063

    Article  CAS  Google Scholar 

  22. Public Health Emergency. Pause in the distribution of bamlanivimab/etesevimab (2021) https://www.phe.gov/emergency/events/COVID19/investigation-MCM/Bamlanivimab-etesevimab/Pages/bamlanivimab-etesevimab-distribution-pause.aspx

  23. Cheng A et al (2020) Outpatient management of COVID-19: rapid evidence review. Am Acad Fam Phys 102(8):478–486. https://www.aafp.org/afp/2020/1015/afp20201015p478.pdf

    Google Scholar 

  24. FDA News Release. Coronavirus (COVID-19) update: FDA authorizes additional monoclonal antibody for treatment of COVID-19. May 26, 2021. https://bit.ly/2SKgYYf. Accessed 15 Sept 2021

  25. The Medical Letter. An EUA for sotrovimab for treatment of COVID-19 (2021, June 28). https://secure.medicalletter.org/w1627a

  26. The Medical Letter. An EUA for casirivimab and imdevimab for COVID-19 (2020, December 28). https://secure.medicalletter.org/w1614a

  27. FDA. Fact sheet for health care providers emergency use authorization (EUA) of bamlanivimab and etesevimab (16, September 2021) https://www.fda.gov/media/145802/download

  28. Memorial Sloan Kettering Cancer Center. Casirivimab and imdevimab (2021, August 31). https://www.mskcc.org/cancer-care/patient-education/casirivimab-and-imdevimab-01

  29. NIH. Anti-SARS-COV-2 monoclonal antibodies (2021, August 4). https://www.covid19treatmentguidelines.nih.gov/therapies/anti-sars-cov-2-antibody-products/anti-sars-cov-2-monoclonal-antibodies/

  30. NIH. Considerations for certain concomitant medications in patients with COVID-19 (2021, August 4) https://www.covid19treatmentguidelines.nih.gov/therapies/concomitant-medications/

  31. Fang L et al (2020) Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med 8(4):e21. https://www.ncbi.nlm.nih.gov/pubmed/32171062

    Article  CAS  Google Scholar 

  32. Patel AB et al (2020) COVID-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what is the evidence? JAMA 323(18):1769–1770. https://www.ncbi.nlm.nih.gov/pubmed/32208485

    CAS  PubMed  Google Scholar 

  33. Mackey K et al (2020) Update alert 3: risks and impact of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers on SARS-CoV-2 infection in adults. Ann Intern Med 173(7):130–131. https://www.ncbi.nlm.nih.gov/pubmed/32845705

    Article  Google Scholar 

  34. Flacco ME et al (2020) Treatment with ACE inhibitors or ARBs and risk of severe/lethal COVID-19: a meta-analysis. Heart 106(19):1519–1524. https://www.ncbi.nlm.nih.gov/pubmed/32611676

    Article  CAS  Google Scholar 

  35. Stockman LJ et al (2006) SARS: systematic review of treatment effects. PLoS Med 3(9):e343. https://www.ncbi.nlm.nih.gov/pubmed/16968120

    Article  Google Scholar 

  36. Rodrigo C et al (2016) Corticosteroids as adjunctive therapy in the treatment of influenza. Cochrane Database Syst Rev 3:CD010406. https://www.ncbi.nlm.nih.gov/pubmed/26950335

    PubMed  Google Scholar 

  37. Arabi YM et al (2018) Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome. Am J Respir Crit Care Med 197(6):757–767. https://www.ncbi.nlm.nih.gov/pubmed/29161116

    Article  Google Scholar 

  38. Fedson DS et al (2020) Hiding in plain sight: an approach to treating patients with severe COVID-19 infection. mBio 11(2). https://doi.org/10.1128/mBio.00398-20

  39. Bancos S et al (2009) Ibuprofen and other widely used non-steroidal anti-inflammatory drugs inhibit antibody production in human cells. Cell Immunol 258(1):18–28. https://www.ncbi.nlm.nih.gov/pubmed/19345936

    Article  CAS  Google Scholar 

  40. Centers for Disease Control and Prevention. COVID-19: Risk for COVID-19 infection, hospitalization, and death by age group (2021, September 9). https://www.cdc.gov/coronavirus/2019-ncov/covid-data/investigations-discovery/hospitalization-death-by-age.html#footnote02

  41. Centers for Disease Control and Prevention, National Center for Health Statistics. Excess deaths associated with COVID-19. Updated April 7, 2021. https://www.cdc.gov/nchs/nvss/vsrr/covid19/excess_deaths.htm

  42. NIH. COVID-19 treatment guidelines: Consideration for certain concomitant medications in patients with COVID-19 (2021, August 4). https://www.covid19treatmentguidelines.nih.gov/therapies/concomitant-medications/

  43. Buttorff C et al (2017) Multiple chronic conditions in the United States. RAND Corporation, Santa Monica, CA. https://www.rand.org/pubs/tools/TL221.html

    Book  Google Scholar 

  44. Center for Medicare & Medicaid Services. National health expenditures 2019 highlights. https://www.cms.gov/files/document/highlights.pdf

  45. Berg S (2021, August 17) What to tell immunocompromised patients about COVID-19 vaccines. AMA Public Health. https://www.ama-assn.org/delivering-care/public-health/what-tell-immunocompromised-patients-about-covid-19-vaccines

  46. Akinbami LJ et al (2021) COVID-19 symptoms and SARS-CoV-2 antibody positivity in a large survey of first responders and healthcare personnel, May-July 2020. Clin Infect Dis. https://doi.org/10.1093/cid/ciab080externalicon

  47. Petersen LR et al (2020) Lack of antibodies to SARS-CoV-2 in a large cohort of previously infected persons. Clin Infect Dis. https://doi.org/10.1093/cid/ciaa1685. https://stacks.cdc.gov/view/cdc/97657

Download references

Author information

Authors and Affiliations

  1. University of Texas Health Science Center at Houston, Houston, TX, USA

    Terri Alvarez

Authors
  1. Terri Alvarez
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Center for Advanced Cardiopulmonary Therapies and Transplantation, Memorial Hermann, Houston, TX, USA

    Amanda Bergeron

  2. Center for Advanced Cardiopulmonary Therapies and Transplantation, Memorial Hermann, Houston, TX, USA

    Russell Perkins

  3. Center for Transplantation, UC San Diego Health System, San Diego, CA, USA

    Emily Ingebretson

  4. Center for Advanced Cardiopulmonary, Memorial Hermann, Houston, TX, USA

    Linda Holifield

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Alvarez, T. (2022). Outpatient Management of COVID-19. In: Bergeron, A., Perkins, R., Ingebretson, E., Holifield, L. (eds) Principles in Nursing Practice in the Era of COVID-19. Springer, Cham. https://doi.org/10.1007/978-3-030-94740-8_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-94740-8_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-94739-2

  • Online ISBN: 978-3-030-94740-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation